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The role of estrogen in bone metabolism is an area of scientific interest
considering the substantial amount of characterized disorders experienced by
individuals. fu order to study the cellular effects of estrogen on osteoblasts, cell
culture techniques have been developed. Commonly utilized cell culture techniques
suggest using DMEM supplemented with 10% FBS. However, DMEM contains
phenol red (a suspected estrogenic compound) and FBS is known to contain estrogen.
fu an attempt to decipher the mechanism through which estrogen elicits its action on

osteoblasts, experimentation necessitated the development of a culturing environment
reduced in estrogenic compounds. The protocol developed reduced the concentration
ofFBS supplementation to 0% through successive, 24-hour incubations with
diminishing amounts of total FBS (1 %, 0.1 %, and 0%). This protocol does not
appear to alter the viability, cell morphology or osteoblast-like phenotype ofUMR106 cell lines when compared to control cells grown in various concentrations of
FBS. As osteoblast-like cell lines are not normally cultured in this manner, there is
the possibility that reducing the concentration of estrogenic compounds in media may

disrupt the osteoblast phenotype. This necessitated corroboration of the maintenance
of recognized osteoblast phenotype markers following culturing according to the
experimental method lead to the application ofRT-PCR quantification of marker
gene expression; we examined six markers characteristic of osteoblasts: AKP, OPG,
RankL, RUNX2, PTHRI, and Procollagen Jell. Although the rate of gene expression
specific for these markers varied, the UMR-106 cultures continued to express
osteoblast specific markers and exhibited estrogen responsiveness.
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Introduction

For each differentiated cell present in a living organism there must be a celltype from which it originated. These original cells are referred to as stem cells or
progenitor cells. In the skeleton, the ossified infrastructure of higher order organisms,
there are multiple cell types originating from a common pluripotent mesenchymal
stem cell. Various proteins, ligands, and cytokine signals are responsible for
conversion of the stem cell into osteoblasts, osteoclasts, chondrocytes, myoblasts, and
adipocytes (Yamaguchi et al., 2000, Pittenger et al., l 999). Each of these cell types,
as well as many others, play pivotal roles in the formation and proper maintenance of
skeletal tissues in the body. For cells to respond to signaling molecules properly they
must express the appropriate receptor. With regards to osteogenic cells, cellular
responsiveness can be observed by the expression of the RANK ligand (RANKL) on
the osteoblast surface and the expression of the RANK receptor (RANKR) on the
osteoclast surface. This interaction is also influenced by essential cytokines and is
held in check by osteoprotegrin (OPG), the decoy receptor for RANKL (Liu et al.,
2005).
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Osteoblasts

Osteoblasts are formed from a population of pluriopotential mesenchymal
stem cells from the bone marrow. As one of the major cell types in bone, osteoblasts
are primarily responsible. for the shape that bone takes as well as the deposition of the
minerals that make it hard (Pittenger et al., 1999). Signal molecules stimulate the
stem cell population to differentiate and commit to becoming osteoblasts. During
differentiation, the cells begin to express phenotypic markers common of osteoblasts.
Some of the key phenotypic markers of osteoblasts are RANKL, RUNX2 (a
transcription factor), alkaline phosphatase (AKP) secretion, and OPG secretion. Once
mature and fully differentiated, osteoblast cells secrete compounds and proteins that
combine to form the bone matrix (Manolagas, 2000; Yamaguchi et al., 2000).
Bone morphogenetic proteins (BMPs) are important signaling molecules in
the pathway leading to osteblast differentiation; BMPs are members of the
transforming growth factor 13 (TGF-13) superfamily and have a role in proper
osteoblast development. At least 15 types of BMPs have been identified in humans
(Hogan, 1996). Genetic disruptions ofBMPs have resulted in various skeletal and
extra-skeletal developmental abnormalities. Signaling activity by BMP is initiated by
interaction with the heterodimeric complex of two transmembrane serine/threonine
kinase receptors, BMPR types I and II, which causes the activated receptor kinases to
phosphorylate the transcription factors Smads 1, 5, or 8 (Hogan, 1996; Peng et al.,
2004).
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In the matrix, osteoblasts regulate the levels of calcium and phosphate within
the compartmentalized bone environment. This management of ion flow leads to the
fo'rmation ofhydroxyapatite as well as other molecules, such as Type I collagen by
osteoblasts. These collagen particles are grouped together into fibrils through a
process of extracellular proteolytic cleavage and the collagen molecules become
interconnected by cross-linkers such as pyridinoline links (Manolagas, 2000;
Compston, 2001; Junqueria et al., 2003).
The expression of target genes is most often the result of a mechanical
stimulus to osteoblasts, and is mediated by portions of gene promoters containing
cAMP response elements and simple stress-response elements. It has been shown
that the ERK and p38 MAPK pathways are involved in this mechanical stress signal
transduction ultimately resulting in osteoblast differentiation (Kletsas et al., 2002).
During the natural or abnormal stretching of bone the mechanical stress causes the
upregulation ofRunx2/Cbfal expression, an osteoblast transcription factor, and also
increases the factor's DNA binding affinity. When this component of the
ERK/MAPK pathway is phosphorylated (Cbfal) there is an observed link between
mechanical stress and osteoblast differentiation (Ziros et al., 2002).

Osteoclasts
Osetoclasts are the primary cell type involved in bone resorption. Osteoclast
progenitors are recruited from the hematopoietic tissue of the monocyte/macrophage
lineage and develop into multinucleated cells. Compared to osteoblasts, osteoclasts
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represent a small fraction of the cells active in living bone. As with osteoblasts,
cytokines and growth factors are vital for proper differentiation. The major
extracellular molecules responsible for osteoclast differentiation are OPG and
RANKL (Li et al., 2000).
The cellular membrane of osteoclasts has a complex enfolding structure
surrounding it which increases the surface area of the cell. A characteristic feature of
osteoclasts is the ruffled border of the plasma membrane; resorption occurs under the
ruffled border where digestive enzymes, recognizing the necessary concentration to
degrade bone, are exocytosed from secretory vesicles (Manolagas, 2000).
The reorganization of the osteoclast cytoskeleton is the first marker for the
resorption cycle carried out by osteoclasts. Actin begins to accumulate in large
bundles, called podosomes, near the osteoclast cell surface facing fully mineralized
bone. A limited number of the proteins involved with this aggregation are known, but
there is evidence that a zone along that side of the cell forms a seal with the
extracellular bone matrix through which the actin cytoskeleton links to it. During this
sealing zone formation the microtubules also form aggregates and extend through the
ruffled border in order to assist movement of molecules to and from the osteoclast
(Sugiyama and Kusuhara, 1994; Mulari et al., 1998). Due to the crystalline structure
ofhydroxyapatite (mineralized bone's main organization) a significant drop in pH is
the only detectable mechanism of resorption. Both membrane-bound proton pumps
and intracellular vacuoles are responsible for the movement of dissolved bone matter,
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consistent with the observation that inhibiting the action of these vacuolar proton
pumps decreases bone resorption (Baron et al., 1985; Sundquist et al., 1990).
There are instances, such as in some diseases, when resorption is
inappropriate and debilitating to the host. Conditions such as osteoporosis and
arthritis are characterized by abnormally increased resorption and turnover of
calcium. These conditions have the potential of causing pathological decreases in
bone mass and a loss of skeletal integrity (Li et al., 2000).

Osteoblastic Markers
Any characteristic that is consistent with a single cell type could be considered
a phenotypic marker. Among cells involved in bone formation and resorption, there
are four that should be considered characteristic: RANKL, RUNX2, AKP, and OPG.
Because these are not all the same type of marker (i.e. a ligand, a transcription factor,
a membrane-anchored dephosphorylating enzyme, and a secreted decoy receptor,
respectfully) each is expressed in response to different stimuli. Other molecular
entities are also involved in cell differentiation, proliferation, and the maintenance of
the calcium (Ca7 in mineralized bone as well as in the remainder of the body.

RANKR and RANKL
Receptor activator of nuclear factor kappa B (RANKR), a member of the
tumor necrosis factor (TNFR) superfamily, is a type I transmembrane protein. In
humans the extracellular domain ofRANKR is a 19.3 kDa protein with 175 amino
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acids. Found on the surface of osteoclast precursors, RANK is involved in the
differentiation of osteoclasts and is capable of initiating osteoclastogenic signal
transduction after ligation with signal transducing molecules such as RANKL, OPG,
anti-RANK agonist antibodies, or any TRANCE (TNF-related activation-induced
cytokine) (Wong et al., 1997).
The activity ofRANKR and its ability to induce osteoclastogenesis is vital to
proper bone resorption and turnover. All of this indicates that RANK is an osteoclast
receptor capable of mediating signal transduction activity during normal bone
homeostasis. It is not clear whether RANK is the sole receptor for OPGL/RANKL,
or whether other TNFR-related proteins could compensate. No other receptors like
RANKR have been identified on the surface of osteoclasts making RANKR possibly
the only receptor for RANKL or other signaling molecules. Knockout mouse models
demonstrate that the RANKR protein and its ligands are critical to proper regulation
of bone mass (Li et al., 2000; Gori et al., 2000).
Receptor of nuclear factor kappa B ligand (RANKL) is expressed on the
surface of mature osteoblasts as a trimeric transmembrane protein and is the main
signaling molecule responsible for determining if osteoclastogenesis occurs or not.
RANKL is also identified as OPGL due to its binding affinity to its decoy receptor,
OPG. This affinity has a direct correlation to the concentration of estrogen found in
the body based on demonstrations that estrogen triggers the up-regulation of OPG
mRNA and protein levels; this is simultaneous with a decrease in the level of
RANKL mRNA and proteins to decrease (Li et al., 2000; Findlay et al., 2008).
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Many calciotropic hormones and proresorptive cytokines have recently been shown to
up-regulate mRNA expression ofRANKL in cell lines and primary cell cultures.
OPG, which blocks osteoclastogenesis induced by OPGL, also can inhibit osteoclast
formation and bone resorption induced by treatment with calciotropic factors,
suggesting that the RANK signaling pathway is the ultimate common mediator of
humoral signals that regulate bone resorption and calcium metabolism (Li et al.,
2000).

RUNX2
While there is still much to learn about Runt-related transcription factor 2
(RUNX2), it is known that RUNX2 is critical in the differentiation of osteoblasts as
well as chondrocyte maturation (Fujita et al., 2004). This includes committing
pluripotential mesenchymal stem cells to the osteoblast lineage, promoting
osteoblastic differentiation at the early stage, and inhibiting differentiation at the late
stage (Enomoto et al., 2003). RUNX2 knockout mice completely lack bone
formation because of the maturational arrest of osteoblasts, indicating that Runx2 is
an essential factor for osteoblast differentiation. In vitro studies have also revealed
that RUNX2 promotes AKP activity, the expression of genes that synthesize bone
matrix proteins, and mineralization in immature mesenchymal cells (Enomoto et al.,
2003; Fujita et al., 2004).
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PTHRJ
Parathyroid hormone receptor-1 (PTHRl) is a G-protein coupled receptor
present on bone cells where it is a dual receptor for parathyroid hormone (PIH) and
parathyroid hormone-related protein (PTHrP); the PTHRl is a member of the G
protein-coupled receptors family (GPCR) which are referred to as class II or family B
receptors (Juppner et al., 1991; Shigeno et al., 1988). It has been shown that the
majority of effects induced by PIH and by PTHrP on developing bone is mediated by
the PTHRI (Lanske et al., 1996). PTHRl receptors are also affected by agonists.
After the initial interaction with agonist molecules the PTHRl complex quickly
internalizes (Bergwitz et al., 1994). The presence of PTHRl among cultured
osteoblast-like cells would indicate maintenance of the osteoblast-like phenotype.

AKP

Alkaline phosphatase (AKP) is anchored to the external surface of the plasma
membrane where it alters the pH of the environment surrounding an osteoblast. It
carries out this activity by hydrolyzing inorganic pyrophosphate (Pi) (Addison et al.,
2007). AKP is commonly found in soft tissues that do not normally exist or attain a
calcified state; it is often characterized by an extracellular fluid with high
concentrations of both calcium and pyrophosphate which inhibits the crystallization
ofhydroxyapatite (Whyte, 1994). Several controversial conclusions were made about
the characterization of AKP until a list of suggested roles was accumulated. AKP is
now characterized by its regulation upon Pi metabolism and Pi constituent molecules,
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conditioning cells to actively transport Pi, Ca++, lipids, and other macromolecules and
ions, and working intracellularly during some stages of embryo genesis (Simko, 1991;
Narisawa et al., 1992). Isoenzymes of AKP are found throughout the body and carry
out similar activities in the kidneys, the bile duct, and the liver (Addison et al., 2007).

OPG
Osteoprotegrin (OPG) is a secretory protein belonging to the TNF receptor
family, synthesized by osteoblasts and recognized as the decoy receptor for RANKL
during optimum conditions. The expression of the OPG gene is subject to the
concentration of estrogen. When conditions are suitable, OPG binds up circulating
RANKL thus preventing RANKL from binding to RANKR and thereby osteoclasts
from receiving the signal to resorb bone (Yeung et al., 2004). Mice with targeted
OPG gene deletion undergo massive osteoporosis, supporting the idea that OPG
prevents osteoclast signaling. Overexpression of the OPG gene in mice causes
increased bone mass as well as reduced resorption (Gori et al., 2000).
The expression of OPG is regulated by a cluster of genes stimulated by the
presence of vitamin D, parathyroid hormone, prostaglandin E2, or interleukin 11,
Calcium can upregulate the expression ofOPG mRNA in vitro. OPG expression
along with Rf.NKL expression is both rate-limiting affectors upon osteoblast
activation and synthesis of products (Kletsas et al., 2002).

Activity ofEstrogen
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Estrogen is a hormone that induces a variety of molecular effects and plays a
significant role in bone formation and resorption. Estrogen induces osteoblasts to
differentiate into osteoclasts, indicating the change from skeletal formation to the
reuptake of bone mineral. Estrogen regulates the expression or repression of the
osteoblastic markers RANKL, AKP, and OPG (Tau, et al., 1997). Estrogen-mediated
upregulation of OPG expression is directly related to the amount of resorption taking
place (Tau, et al., 1997; Gori et al., 2000; Stejskal et al., 2001).

Sig11ijica11ce ofStudy
Estrogen has many effects on osteoblasts in vivo and in vitro. In long-term
cultures ofrat osteoblast-like cells, estrogen stimulates cell proliferation in a dosedependent fashion, increasing the cell growth two-fold and also increasing the
expression of AKP and type I collagen (Majeska et al., 1994). Mature osteoblasts
should be able to secrete AKP and type I collagen, phenotypic markers of osteoblastic
differentiation and bone mineralization (Majeska et al. 1994, Manolagas, 2000).
Studies of cultured osteoblast-like cells demonstrated that AKP is up-regulated by
estrogen in a dose dependent manner (Gray et al. 1987). Majeska and colleagues
(1994) reported that estrogen inhibits the activation of a cAMP-dependent pathway
required for the bone resorption processes initiated by parathyroid hormone and
prostaglandin E2. Similarly, Chow et al. (1992) showed that estrogen not only
suppresses the bone resorption cascade, but stimulates bone formation. Osteoblasts
treated with estrogen have reduced production of Interleukin-6 (IL-6) and Interleukin-
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1 (IL-1) (Qu et al., 1999). These cytokines inhibit the differentiation of osteoclast
precursors to a multinucleated osteoclastic cell type, thereby decreasing their
resorptive nature. Estrogen also appears to inhibit osteoclastic bone resorption by
mediating osteoclast apoptosis through an estrogen receptor-mediated mechanism
(Karneda et al., 1997). The further discovery of estrogen receptors in osteoblasts may
implicate osteoblasts as estrogen's specific target (Eriksen et al., 1980).
Estrogen's presence or absence regulates genes in the molecular pathway
through which skeletal integrity is maintained; these mechanisms involve interaction
between RANK, RANKL, and OPG. RANKL is involved in the development of
functional osteoclasts. The RANKIRANKL complex enhances osteoclast activity by
inhibiting osteoclast apoptosis (Lam et al., 2001, Riggs et al., 2002) and provides an
essential signal for osteoclast differentiation (Yasuda et al., 1998). RANKL
supplementation in culture medium activates mature osteoclasts in vitro in a dosedependent manner (Bolye et al., 2003, Jirni et al., 1999). In contrast, osteoprotegerin
(OPG), a decoy receptor expressed by osteoblasts, prevents the interaction of
RANKL with RANK (Hsu et al., 1999). OPG competes with RANK, blocking the
differentiation and function of the osteoclasts. Estrogen up-regulates OPG mRNA
and protein levels. The absence of estrogen down-regulates OPG, favoring osteoclast
differentiation (Saika et al., 2001).

Preliminary I11vestigatio11
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Standard cell culture methods typically suggest using DMEM supplemented
with 10% FBS. However, DMEM contains phenol red (a suspected estrogenic

I
I

compound) and FBS is known to contain estrogen. iJn an attempt to decipher the
mechanism through which estrogen elicits its actiori on osteoblasts, experimentation
necessitated the development of a culturing envirolent reduced in estrogenic
compounds. A protocol to reduce estrogenic compJunds was developed which

I
demonstrated that osteoblast-like cell lines will continue to express the necessary
markers of typical osteoblasts after progressive remlval of estrogen from the medium

I
(Ganguly et al., 2008). It has also been shown that phenotypic markers expressed

I

both within and on the outer membrane of cells can lbe dependent upon cell to cell
contact (Geng et al., 2001). Within organismal tissue, however, these cells are not
I

always arranged in a confluent state and therefore rJly on chemical messengers which

I

pass through the extracellular environment. Quantification of these messengers is
I
I

possible through the use of Real-time PCR (RT-PCR).

Culturing Protocol to Reduce Estrogenic Influences
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Cells grown in 10% FBS-supplemented DMEM media were switched to
OPTI-MEM (Invitrogen) media, an enriched medium devoid of phenol red.
Transferring the cells from 10% FBS-supplemented DMEM to OPTI-MEM required
a stepwise reduction of the FBS concentration, effectively weaning the cells from
FBS. Cells grown in 10% FBS-supplemented DMEM were passed to 5% FBSsupplemented DMEM upon reaching confluence. Cells were allowed to grow to
confluence in the 5% FBS-supplemented DMEM and then passed to 1% FBSsupplemented OPTI-MEM. Once the cells in 1% FBS-supplemented OPTI-MEM
reached confluence, they were passed to various lower concentrations ofFBSsupplemented OPTI-MEM (Figure 1).
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Culture Cells in 1°/4
FBS-Supplimented
OPTI-MEM Media

&LE-3 ~···t:.3

• 3 C?,E-3
•

~

~

Culture Cells in 0.1% OPTI-MEM Mediafor24hrs

~

Feed Cells with 0% OPTI-MEM Media every 24hrs
following a PBS Wash

•

Perform Real Time-PCR
following 96 hrs of exp.
treatment
Figure 1. Flow chart diagramming cell culture procedure as used in preliminary
research. Osteoblast-Iike' UMR-106 cells were gradually weaned off of potentially
estrogenic compounds either normally placed in the media or supplemented by the
researcher.
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Cell Viability Determination from Long-Term Cultures in a Reduced FBS
Environment
Cells were grown to confluence in 1% FBS-supplemented OPTI-MEM. The
cells were passed and distributed equally between six 25cm2 flasks containing 0.1 %
FBS-supplemented OPTI-MEM. Following a 24 hr incubation, the media was
aspirated and the cells were washed with 3ml of sterile PBS and media devoid of FBS
(0% OPTI-MEM) was added. Cultures were allowed to grow continuously
throughout the protocol. PBS washes and feedings occurred at 24 hr intervals with the
appropriate media for the duration of experimentation (14 days). Prior to each wash,
representative photographs of the cells were taken to document cell morphology
(Figure 2).
The difference between the estrogenic compound concentrations ofDMEM
supplemented with 10% FBS and OPTI-MEM supplemented with 0% FBS lead to a
comparison of survivability between the two media types to indicate that media
devoid of estrogenic compounds has no detrimental effects on the long-term culture
of cells. Cells were allowed to grow to confluency for the duration of the experiment
after which cell viability was determined using trypan blue exclusion. The plotted
results of Figure 3 indicate that cells cultured in media devoid of estrogenic
compounds exhibited higher percent cell viability than those grown with FBS
supplementation (Figure 3). This could be due to the FBS supplemented cultures
reaching confluency first and then competition for nutrients caused exclusion, but as
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anticipated the cells grown without estrogenic supplementation were able to grow for
nearly a week longer and had higher cell viability.
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A

B

C

D

E

F

DMEM

OPTI-MEM

Figure 2. Micrographs showing the cell morphology ofUMR-106 cells cultured for
72 hours in various concentrations ofFBS in DMEM (A, B, C) or OPTI-MEM (D, E,

F). UMR-106 cells showed minimal difference in gross morphology following a
reduction ofFBS supplementation when passed from I 0% (A) to 5% (B) or 1% (C).
UMR-106 cells were passed to I% OPTI-MEM (D) from 5% DMEM and then
further reduced to 0.1 % (E) and 0% (F) from 1% stock cultures without any apparent
change in morphology. Original magnifications are at 200X.
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Figure 3. Time course comparing the survivability ofUMR-106 cells incubated in
DMEM supplemented with 10% FBS (closed circles) and UMR-106 cells cultured in
OPTI-MEM supplemented with 0% FBS (open squares). Cell viability was
determined by trypan blue exclusion. Data are expressed as mean ± SEM.
Significance is indicated between treatments within corresponding days. (p < 0.01)
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Materials and Methods
Cell Culture
UMR-106 cells derived from rat osteosarcoma cells were obtained from
American Type Tissue Collection (ATCC) (Manassas, VA.) and maintained in
Dulbecco's modified Eagle medium (DMEM) (Invitrogen, Chicago, IL)
supplemented with 10% fetal bovine serum (FBS, Invitrogen), l00units mL- 1
penicillin G and IO0µg mL- 1 streptomycin (Sigma, St. Louis, MO); according to
Invitrogen 10% FBS contains 21.4 pg/mL of estrogen. Cells were plated onto 75cm2
culture flasks, allowed to grow to confluence and then subsequently weaned off of
estrogen by reducing the FBS supplementation as per the culturing protocol (Figure
1). Cultures were maintained at 37°C in a humidified atmosphere of5% CO2 in air
with culture media changed every 48 to 72 hrs. Detachment of cells was
accomplished by the addition of a trypsin/ethylene diaminetetraacetic acid (EDTA)
solution (Invitrogen) in phosphate buffered saline (PBS).
Due to the volume of culturing attempted each treatment was performed
from beginning to finish before moving to the next treatment. Following detachment
cells were then spun down in a 1.8 mL eppendorftube and the pellets stored in liquid
nitrogen until cell culturing was completed.
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Estrogen Supplementation
UMR-106 cells were cultured according to the previously established
protocol involving 0% FBS supplemented OTPI-MEM, 10% FBS supplemented
DMEM and 10% Charcoal Stripped FBS (CS-FBS) (Invitrogen) supplemented
DMEM as described above. To evaluate estrogen responsiveness between the cells
cultured in the different media cells were exposed to either 0, 0.5 or lmM ~ estradiol
(Sigma) twenty four hours prior to harvesting.

RNA Isolation
RNA isolation was performed utilizing the Qiagen RNeasy mini-spin
kit. Previously stored cell pellets were loosened and Buffer RLT was added
according to the supplied Qiagen instructions to lyse the cells. After lysis 600 uL of
70% ethanol was added and was mixed by pipetting. Once homogenized 700 uL of
sample was transferred into an RNeasy spin column (in a 2 mL eppendorftube) and
centrifuged for 15 sec. at 10,000 rpm; flow-through was discarded following this step.
700 uL of Buffer RWl was then added to the spin column and centrifuged for 15 sec.
at 10,000 rpm; flow-through was discarded following this step. 'Two washes were
then performed using 500 uL of Buffer RPE, the first was spun for 15 sec. at 10,000
rpm and the second for two min. at 10,000 rpm; flow-through was discarded and the
spin column was removed following this step. The spin column was then placed in a
1.5 mL eppendorftube (supplied by Qiagen) and 50 uL RNase-free water was added
to the column membrane. The 1.5 mL tube was then spun for one min. at 10,000 rpm
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to elute the RNA. The resulting RNA samples were quantified using a Nanodrop
Spectrophotometer (Wilmington, DE) and frozen for use in making cDNA.

cDNA Formation and Real-Time PCR
Complementary DNA (cDNA) was made from lµg of each sample
using the Applied Biosytems cDNA Archive Kit according to the manufacturer's
instructions in a volume of 100 µL; samples were frozen until analyzed. The cDNA
products were analyzed with an Applied Biosystems 7300 Real-Time PCR System
(Foster City, CA) using 5µ1 of cDNA in a total reaction volume of25µ1; each reaction
included probes for the specific osteoblast phenotypic marker, RNase-free water, and
sample cDNA. The Applied Biosystems probes used were: 18s (4333760F); OPG rat
(Rn00563499); RANKL rat (Rn00589289); AKP rat (Rn01516028) and RUNX2 rat
(Rn0 1512296). Expression values are presented as Ct values for each probe after
normalization to 18s expression (Ctmarker-Ct 1s,) (Figures 4-15).
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Results
Effects of Media Type on UMR-106 Cell Line
AKP

UMR-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - 10% FBS-supplemented DMEM, 10% CF FBSsupplemented DMEM and 0% FBS-supplemented OPTI-MEM. After culturing, the
presence of AKP mRNA in the original cultured cells was quantified using RT-PCR;
the data from the RT-PCR measurements indicate the amount of original mRNA that
was used in conversion to cDNA for RT-PCR quantifications. Figure 4 identifies the
AKP mRNA levels with regard to each culturing media with a significant difference
(p<0.05) between cells grown in 0% FBS-supplemented OPTI-MEM media (7.88±
0.74) and cells grown in 10% FBS-supplemented DMEM (9.84±0.20) and 10% CF
FBS-supplemented DMEM (9.95±0.43); cultured cells continue to present osteoblastlike phenotypic markers as those do in media with estrogen.
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Effect of Media Type on AKP Expression
Figure 4. Comparison ofUMR-106 gene expression for AKP in 0% FBS
supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values ± SEM for cells cultured in media for 96 hrs. Significance is
indicated with an asterisk (p < 0.05) when comparing the 0% FBS supplemented
OPTI-MEM to the 10% FBS supplemented DMEM and 10% FBS-CS supplemented
DMEM. Values were normalized to 18s expression.
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OPG

UMR-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - 10% FBS-supplemented DMEM, 10% CF FBSsupplemented DMEM and 0% FBS-supplemented OPTI-MEM. After culturing, the
presence of OPG mRNA in the original cultured cells was quantified using RT-PCR;
the data from the RT-PCR measurements indicate the amount of original mRNA that
was used in conversion to cDNA for RT-PCR quantifications. Figure 5 identifies the
OPG mRNA levels with regard to each culturing media with a significant difference
(p<0.05) between cells grown in 0% FBS-supplemented OPTI-MEM media (15.78±
0.72) and cells grown in 10% FBS-supplemented DMEM (17.64±0.20) and 10% CF
FBS-supplemented DMEM (19.31±0.42); cultured cells continue to present
osteoblast-like phenotypic markers as those do in media with estrogen.
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Effect of Media Type on OPG Expression
Figure 5. Comparison ofUMR-106 gene expression for OPG in 0% FBS

supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), I 0% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values ± SEM for cells cultured in media for 96 hrs. Significance is
indicated with an asterisk (p < 0.05) when comparing the 0% FBS supplemented
OPTI-MEM to the 10% FBS supplemented DMEM and 10% FBS-CS supplemented
DMEM. Values were normalized to 18s expression.
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Pro-collage11 1al
UMR-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - I 0% PBS-supplemented DMEM, I 0% CF FBSsupplemented DMEM and 0% PBS-supplemented OPTI-MEM. After culturing, the
presence of Pro-collagen mRNA in the original cultured cells was quantified using
RT-PCR; the data from the RT-PCR measurements indicate the amount of original
mRNA that was used in conversion to cDNA for RT-PCR quantifications. Figure 6
identifies the Pro-collagen mRNA levels with regard to each culturing media with a
significant difference (p<0.05) between cells grown in 0% PBS-supplemented OPTIMEM media (7.55± 0.70) and cells grown in 10% PBS-supplemented DMEM
(10.86±0.24) and 10% CF PBS-supplemented DMEM (11.07±0.34); cultured cells
continue to present osteoblast-like phenotypic markers as those do in media with
estrogen.
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Effect of Media Type on Pro-Collagen Expression
Figure 6. Comparison ofUMR-106 gene expression for Pro-Collagen in 0% FBS
supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values ± SEM for cells cultured in media for 96 hrs. Significance is
indicated with an asterisk (p < 0.05) when comparing the 0% FBS supplemented
OPTI-MEM to the 10% FBS supplemented DMEM and 10% FBS-CS supplemented
DMEM. Values were normalized to 18s expression.
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PTHRJ
UMR.-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - 10% FBS-supplemented DMEM, 10% CF FBSsupplemented DMEM and 0% FBS-supplemented OPTI-MEM. After culturing, the
presence of PTHR.1 mRNA in the original cultured cells was quantified using RTPCR; the data from the RT-PCR measurements indicate the amount of original
mRNA that was used in conversion to cDNA for RT-PCR quantifications. Figure 7
identifies the PTHR.1 mRNA levels with regard to each culturing media with a
significant difference (p<0.05) between cells grown in 0% FBS-supplemented OPTIMEM media (10.42± 0.13) and cells grown in 10% FBS-supplementedDMEM
(13.11±) and 10% CF FBS-supplemented DMEM (12.18±0.39); cultured cells
continue to present osteoblast-like phenotypic markers as those do in media with
estrogen.
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Effect of Media Type on PTHR1 Expression
Figure 7. Comparison ofUMR-106 gene expression for PTHRI in 0% FBS
supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values ± SEM for cells cultured in media for 96 hrs. Significance is
indicated with an number sign (p < 0.05) when comparing the 0% FBS supplemented
OPTI-MEM to the 10% FBS supplemented DMEM. Values were normalized to 18s
expression.
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Ra11kL
UMR-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - 10% FBS-supplemented DMEM, 10% CF FBSsupplemented DMEM and 0% FBS-supplemented OPTI-MEM. After culturing, the
presence ofRankL mRNA in the original cultured cells was quantified using RTPCR; the data from the RT-PCR measurements indicate the amount of original
mRNA that was used in conversion to cDNA for RT-PCR quantifications. Figure 8
identifies the RankL mRNA levels with regard to each culturing media with a
significant difference (p<0.05) between cells grown in 0% FBS-supplemented OPTIMEM media (15.37± 0.88) and cells grown in 10% FBS-supplemented DMEM
(15.55±0.54) and 10% CF FBS-supplemented DMEM (15.50±0.34); cultured cells
continue to present osteoblast-like phenotypic markers as those do in media with
estrogen.

30

20

.----------------------------,

gi

:::J

15

~

+'
u

"C
Cl)

IO

.!::!

'Eca
"C

C

J!!

en

5

0

O¾FBS

Effect of Media Type on Rankl Expression
Figure 8. Comparison ofUMR-106 gene expression for RankL in 0% FBS
supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values± SEM for cells cultured in media for 96 hrs. Values were
normalized to 18s expression.
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RUNX2
UMR-106 cells cultured following the developed protocol were grown
in 3 distinct types of media - 10% FBS-supplemented DMEM, 10% CF FBSsupplemented DMEM and 0% FBS-supplemented OPTI-MEM. After culturing, the
presence ofRUNX2 mRNA in the original cultured cells was quantified using RTPCR; the data from the RT-PCR measurements indicate the amount of original
mRNA that was used in conversion to cDNA for RT-PCR quantifications. Figure 9
identifies the RUNX2 mRNA levels with regard to each culturing media with a
significant difference (p<0.05) between cells grown in 0% FBS-supplemented OPTIMEM media (15.15± 0.61) and cells grown in 10% FBS-supplemented DMEM
(12.43±0.25) and 10% CF FBS-supplemented DMEM (12.64±.08); cultured cells
continue to present osteoblast-like phenotypic markers as those do in media with
estrogen.
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Effect of Media Type on RUNX2 Expression
Figure 9. Comparison ofUMR-106 gene expression for RUNX2 in 0% FBS
supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). Bars represent standardized
mean Ct values ± SEM for cells cultured in media for 96 hrs. Significance is
indicated with an asterisk (p < 0.05) when comparing the 0% FBS supplemented
OPTI-MEM to the 10% FBS supplemented DMEM and 10% FBS-CS supplemented
DMEM. Values were normalized to 18s expression.
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Effect of Culturi11g Protocol 011 Estroge11 Respo11sive11ess
AKP

While following the developed protocol,

~

estradiol was added 24

hours prior to cell harvesting; estrogen was supplanted at 0 mM, 0.5 mM, and 1.0
mM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence of AKP mRNA in the original cultured cells was quantified
using RT-PCR; the data from the RT-PCR measurements indicate the amount of
original mRNA that was used in conversion to cDNA for RT-PCR quantifications.
Figure 10 identifies the AKP mRNA levels with regard to each culturing media and
concentration of~ estradiol supplementation. Significant differences between cells
given estrogen and those not in comparison to their media are identified; cells grown
in media reduced of estrogenic compounds maintained sensitivity to estrogen
stimulation in a manner similar to those cultured in media with estrogen.
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AKP Expression Following Estrogenic Compound Supplementation
Figure 10. ~ Estradiol responsiveness ofUMR-106 gene expression for AKP in 0%
FBS supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). For each osteoblastic marker
three sets of data are presented. The first bar in each set represents cultures not
exposed to exogenous ~ estradiol supplementation, the second bar represents cultures
exposed to 0.5 mM exogenous ~ estradiol supplementation and the third bar
represents cultures exposed to 1 mM exogenous p estradiol supplementation. Bars
represent standardized mean Ct values ± SEM for cells cultured in media with or
without Pestradiol for 96 hrs. Significance is indicated between experimental
treatments exposed to exogenous p estradiol and their corresponding treatment not
exposed to exogenous Pestradiol for each of the genes analyzed with an asterisk (p <
0.05). Values were normalized to 18s expression.
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OPG
While following the developed protocol, ~ estradiol was added 24
hours prior to cell harvesting; estrogen was supplanted at 0 mM, 0.5 mM, and 1.0
mM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence of OPG mRNA in the original cultured cells was quantified
using RT-PCR; the data from the RT-PCR measurements indicate the amount of
original mRNA that was used in conversion to cDNA for RT-PCR quantifications.
Figure 11 identifies the OPG mRNA levels with regard to each culturing media and
concentration of~ estradiol supplementation. Significant differences between cells
given estrogen and those not in comparison to their media are identified; cells grown
in media reduced of estrogenic compounds maintained sensitivity to estrogen
stimulation in a manner similar to those cultured in media with estrogen.
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Supplementation
Figure 11. ·P Estradiol responsiveness ofUMR-106 gene expression for OPG in 0%
FBS supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM (shaded
bars), 10% FBS-CS supplemented DMEM (black bars). For each osteoblastic marker
three sets of data are presented. The first bar in each set represents cultures not
exposed to exogenous Pestradiol supplementation, the second bar represents cultures
exposed to 0.5 mM exogenous p estradiol supplementation and the third bar
represents cultures exposed to 1 mM exogenous p estradiol supplementation. Bars
represent standardized mean Ct values ± SEM for cells cultured in media with or
without p estradiol for 96 hrs. Significance is indicated between experimental
treatments exposed to exogenous p estradiol and their corresponding treatment not
exposed to exogenous Pestradiol for each of the genes analyzed with an asterisk (p <
0.05). Values were normalized to 18s expression.
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Pro-collagen Jal
While following the developed protocol, ~ estradiol was added 24
hours prior to cell harvesting; estrogen was supplanted at 0 mM, 0.5 mM, and 1.0
mM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence of Pro-collagen mRNA in the original cultured cells was
quantified using RT-PCR; the data from the RT-PCR measurements indicate the
amount of original mRNA that was used in conversion to cDNA for RT-PCR
quantifications. Figure 12 identifies the Pro-collagen mRNA levels with regard to
each culturing media and concentration of~ estradiol supplementation. Significant
differences between cells given estrogen and those not in comparison to their media
are identified; cells grown in media reduced of estrogenic compounds maintained
sensitivity to estrogen stimulation in a manner similar to those cultured in media with
estrogen.
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Pro-Collagen Expression Following Estrogenic Compound
Supplementation
Figure 12. p Estradiol responsiveness ofUMR-106 gene expression for ProCollagen in 0% FBS supplemented OPTI-MEM (open bars), 10% FBS supplemented
DMEM (shaded bars), 10% FBS-CS supplemented DMEM (black bars). For each
osteoblastic marker three sets of data are presented. The first bar in each set
represents cultures not exposed to exogenous Pestradiol supplementation, the second
bar represents cultures exposed to 0.5 mM exogenous p estradiol supplementation
and the third bar represents cultures exposed to I mM exogenous p estradiol
supplementation. Bars represent standardized mean Ct values ± SEM for cells
cultured in media with or without p estradiol for 96 hrs. Significance is indicated
between experimental treatments exposed to exogenous Pestradiol and their
corresponding treatment not exposed to exogenous Pestradiol for each of the genes
analyzed with an asterisk (p < 0.05). Values were normalized to 18s expression.
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PTHRJ
While following the developed protocol,

p estradiol was added 24

hours prior to cell harvesting; estrogen was supplanted at 0 mM, 0.5 mM, and 1.0
mM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence of PTHRl mRNA in the original cultured cells was
quantified using RT-PCR; the data from the RT-PCR measurements indicate the
amount of original mRNA that was used in conversion to cDNA for RT-PCR
quantifications. Figure 13 identifies the PTHRl mRNA levels with regard to each
culturing media and concentration of pestradiol supplementation. Significant
differences between cells given estrogen and those not in comparison to their media
are identified; cells grown in media reduced of estrogenic compounds maintained
sensitivity to estrogen stimulation in a manner similar to those cultured in media with
estrogen.
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PTHR1 Expression Following Estrogenic Compound
Supplementation
Figure 13. p Estradiol responsiveness ofUMR-106 gene expression forPTHRl in
0% FBS supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM
(shaded bars), 10% FBS-CS supplemented DMEM (black bars). For each
osteoblastic marker three sets of data are presented. The first bar in each set
represents cultures not exposed to exogenous p estradiol supplementation, the second
bar represents cultures exposed to 0.5 mM exogenous p estradiol supplementation
and the third bar represents cultures exposed to 1 mM exogenous p estradiol
supplementation. Bars represent standardized mean Ct values ± SEM for cells
cultured in media with or without pestradiol for 96 hrs. Significance is indicated
between experimental treatments exposed to exogenous Pestradiol and their
corresponding treatment not exposed to exogenous Pestradiol for each of the genes
analyzed with an asterisk (p < 0.05). Values were normalized to 18s expression.
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RankL
While following the developed protocol, Pestradiol was added 24
hours prior to cell harvesting; estrogen was supplanted at 0 rnM, 0.5 rnM, and 1.0

rnM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence ofRankL mRNA in the original cultured cells was quantified
using RT-PCR; the data from the RT-PCR measurements indicate the amount of
original mRNA that was used in conversion to cDNA for RT-PCR quantifications.
Figure 14 identifies the RankL mRNA levels with regard to each culturing media and
concentration of Pestradiol supplementation. Significant differences between cells
given estrogen and those not in comparison to their media are identified; cells grown
in media reduced of estrogenic compounds maintained sensitivity to estrogen
stimulation in a manner similar to those cultured in media with estrogen.
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RankL Expression Following Estrogenic Compound
Supplementation
Figure 14. ~ Estradiol responsiveness ofUMR-106 gene expression forRankL in
0% PBS supplemented OPTI-MEM (open bars), 10% PBS supplemented DMEM
(shaded bars), 10% PBS-CS supplemented DMEM (black bars). For each
osteoblastic marker three sets of data are presented. The first bar in each set
represents cultures not exposed to exogenous ~ estradiol supplementation, the second
bar represents cultures exposed to 0.5 mM exogenous ~ estradiol supplementation
and the third bar represents cultures exposed to I mM exogenous ~ estradiol
supplementation. Bars represent standardized mean Ct values ± SEM for cells
cultured in media with or without ~ estradiol for 96 hrs. Significance is indicated
between experimental treatments exposed to exogenous ~ estradiol and their
corresponding treatment not exposed to exogenous ~ estradiol for each of the genes
analyzed with an asterisk (p < 0.05). Values were normalized to 18s expression.
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RUNX2
While following the developed protocol, ~ estradiol was added 24
hours prior to cell harvesting; estrogen was supplanted at 0 mM, 0.5 mM, and 1.0
mM concentrations in each culture flask among the 3 media types used. After
harvesting, the presence ofRUNX2 mRNA in the original cultured cells was
quantified using RT-PCR; the data from the RT-PCR measurements indicate the
amount of original mRNA that was used in conversion to cDNA for RT-PCR
quantifications. Figure 15 identifies the RUNX2 mRNA levels with regard to each
culturing media and concentration of~ estradiol supplementation. Significant
differences between cells given estrogen and those not in comparison to their media
are identified; cells grown in media reduced of estrogenic compounds maintained
sensitivity to estrogen stimulation in a manner similar to those cultured in media with
estrogen.
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RUNX2 Expression Following Estrogenic Compound
Supplementation
Figure 15. p Estradiol responsiveness ofUMR-106 gene expression for RUNX2 in
0% FBS supplemented OPTI-MEM (open bars), 10% FBS supplemented DMEM
(shaded bars), 10% FBS-CS supplemented DMEM (black bars). For each
osteoblastic marker three sets of data are presented. The first bar in each set
represents cultures not exposed to exogenous p estradiol supplementation, the second
bar represents cultures exposed to 0.5 mM exogenous p estradiol supplementation
and the third bar represents cultures exposed to 1 mM exogenous p estradiol
supplementation. Bars represent standardized mean Ct values ± SEM for cells
cultured in media with or without p estradiol for 96 hrs. Significance is indicated
between experimental treatments without exogenous p estradiol supplementation with
an 'at'symbol (p < 0.05) when compared to the 0% FBS culture. Significance is
indicated between experimental treatments exposed to exogenous p estradiol and their
corresponding treatment not exposed to exogenous p estradiol for each of the genes
analyzed with an asterisk (p < 0.05). Values were normalized to 18s expression.
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Discussion

The goal of this project was to verify the maintenance of the osteoblast-like
phenotype expressed byUMR-106 cells following culture in an estrogen-reduced
media environment. This "osteoblast-like phenotype" can be identified in terms of
typical extracellular markers and intracellular products of processes associated with
osteoblasts as well as the conversion of osteoblasts to osteoclasts with regards to the
amount of estrogen present in solution. Because there are documented
pathophysiologies related to circulating estrogen concentrations and improper skeletal
health (directly related to improper osteoblast function) then a cell culturing protocol
involving reduced estrogen levels would be advantageous for studying such diseases.
Standard tissue culturing methods utilize media that contains pH indicator
phenol red which may have estrogenic properties (Ernst et al. 1989, Nasu et al. 2002)
and often contains supplementation. Information from Invitrogen states that media
supplemented with 10% FBS contains contains 21.4 pg/mM of estrogen (Invitrogen).

It is shown that osteoblasts do, however, require estrogen to activate various internal
mechanisms, such as the formation of pro-collagen Jal which is used in bone
formation done by osteoblasts (Manolagas, 2000; Compston, 2001). Any developed
protocol must maintain the ability for the cells to respond to estrogen and should
attempt to lower native estrogen concentrations as much as possible.
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The developed cell culture protocol gradually weans the UMR-106 cells from
media containing phenol red and supplemented with FBS to media that does not
contain phenol red and is not supplemented with FBS as shown in Figures 4-9. After
UMR-106 cells were cultured following this protocol the amount of mRNA originally
present was quantified using RT-PCR in order to show evidence that osteoblast-like
cells maintain their phenotype after growth in an environment lacking estrogen
supplementation. In addition we tested the ability of these cells to retain their
responsiveness to estrogen supplementation. present.
As mentioned previously alkaline phosphatase functions to modify the pH of
an osteoblast-like cells environment and is anchored to the external surface of the
plasma membrane (Addison et al., 2007). The UMR-106 cells used in the protocol
development also expressed AKP which enabled experimentation by Ganguly et al.
(2008) to see if the absence of estrogen effected this expression; micrographs (not
shown) showed that AKP presence/activity is unaffected by the absence of estrogenic
compounds as imposed by the cell culture protocol.

It has already been shown that the established cell culturing protocol does not
alter cell morphology (Figure 2) nor does it alter cell viability in a dramatic way
(Figure 3); cells grown with 0% FBS experienced slower growth and therefore did
not experience the overgrowth and death that cells grown in 10% FBS did. The
identified phenotypic markers were examined regarding the amount of original
mRNA extracted from cells following culture according to the designed protocol
(Figure 1).
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As stated previously, alkaline phosphatase should be present on or around the
outer surface of non-calcified tissues that lie in fluid with high concentrations of
calcium and pyrophosphate; this description qualifies osteoblast-like cells as potential
targets. Analysis of AKP gene expression showed that AKP was still present during
culture even in a media reduced in estrogenic compounds (Figure 4). Similar analysis
of AKP gene expression after cells were stimulated with ~ estradiol showed that AKP
levels decreased significantly (p<0.05) compared to cells cultured in media composed
of estrogenic compounds (Figure 10). This should be expected because estrogen
upregulates the process of bone resorption therefore decreasing osteoblast activity and
increasinig the differentiation of osteoclasts (Fujita et al., 2004).
Osteoprotegrin, like some of the other phenotypic markers, is also regulated
by the presence or absence of estrogenic compounds - an increase of estrogen results
in an increase of OPG and therefore leads to more opportunity for OPG to bind to
RANKL thus preventing bone resorption (Bord et al. 2003, Stejskal et al. 2001).
Analysis of OPG following culture in media as per the developed culturing protocol
showed an increase, however, in the mRNA produced by the OPG gene when UMR106 osteoblast-like cells were cultured in media reduced in estrogenic compounds
(Figure 5). It was also shown through analysis that UMR-106 cells produce OPG in
response to ~ estradiol stimulation however in a significantly (p<0.05) decreased
marmer, continuing to follow the trend outlined previously (Figure 11). One
possibility is that the media being used contained trace amounts of estrogenic
compounds therefore corrupting the readings; it is possible that the trace compounds
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came from the culturing flasks or that the estrogen came from the FBS left in or on
the cultured cells after splitting. It is also possible that chemicals from the FBS were
left in or on the cells or the culture flask surface from the initial FBS exposure when
they were split.
The function of Pro-collagen la.I molecules as intermediates in the bone
forming process is an important indicator in the case of proper osteoblast function.
As indicated before, the fibrils formed via the linkage of multiple collagen molecules
are an integral part to bone formation, similar to hydroxyapatite function. Analysis of
Pro-collagen la.I gene expression increased during culture even in a media reduced in
estrogenic compounds (Figure 6) which, while against previous evidence of estrogen
dependence, may indicate culturing media alone supplies sufficient nutrients for bone
deposition. Further analysis of Pro-collagen la.I following~ estradiol stimulation
(Figure 12) indicated a similar pattern of expression, however, a significantly
different (p<0.05) amount occurred in the I 0% charcoal filtered FBS media. This
may be indicative of quantifiable threshold of estrogen necessary for proper bone
formation.

In order for parathyroid hormone and its related protein to play a role in the
cycle of bone formation and resorption osteoblasts must express PTHRl receptors;
for that reason an osteoblast-like cell should also express PTHRI receptors properly
in order for experimental use. Analysis of PTHRI gene expression following cell
culture indicated a significantly different (p<0.05) increase in the level of gene
product in cells cultured in media reduced in estrogen (Figure 7) compared to other
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media used. Additional analysis after p estradiol stimulation resulted in a similar
pattern of decreased expression in result to estrogen's presence (Figure 13). This
pattern may indicate that PTHRl is utilized in the absence of estrogen by osteoblastlike cells; results of the 10% charcoal filtered FBS media may also indicate the place
where PTHRl responsiveness meets in equilibrium with cell estrogen responsiveness
as the gene expression is nearly identical between those stimulated and those cells not
stimulated with p estradiol.
The surface molecule RANKL is identified as being crucial regarding the
differentiation process of osteoblasts into osteoclasts; when estrogen is in sufficient
amounts there should be enough circulating OPG to bind up the RANKL and prevent
differentiation thus leading to bone formation (Bord et al., 2003). Alternatively,
when the amount of estrogen is less than sufficient, osteoclasts bind to RANKL and
osteoclastogenesis occurs. Regarding the established cell culturing protocol and the
reasons behind its conception the analysis ofRANKL was obviously required.
Analysis ofRANKL gene expression for each of the media used (Figure 8) showed
no significant difference between cells cultured indicating that estrogen was not
necessary for RANKL expression i.e. the physical presence ofRANKL. Further
analysis (Figure 14) following

p estradiol stimulation gaye mixed results with a

significantly different increase (p<0.05) of expression without p estradiol stimulation
versus similar cell cultures that were stimulated. Other results following stimulation
showed no significant change in cells cultured in 10% FBS media, but a significant
difference (p<0.05) between cells grown in 10% charcoal filtered FBS media and
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those cells grown similarly and stimulated with pestradiol. These findings indicate
that estrogen is not required for RANKL expression, that estrogen does effect
RANKL expression however, and that the concentration of estrogen present does not
wholly change the effect estrogen has on RANKL expression.
RUNX2 function as a transcription factor leads pluripotential stem cells to
become osteoblasts as well as osteoblast differentiation (Fujita et al., 2004). Analysis
of RUNX2 gene expression following cell culture in the utilized media (Figure 9)
showed a significantly different (p<0.05) decrease in RUNX2 activity when
comparing media reduced in estrogenic compounds to media containing estrogenic
compounds. Cells cultured in this manner were exposed to exogenous

Pestradiol

prior to harvesting as well. Analysis of these results showed no significant difference
between the media reduced in estrogenic compounds compared to those cultured cells
after p estradiol stimulation; however, significant differences (p<0.05) were found
between cells grown in 10% FBS supplemented media and those culured cells after p
estradiol stimulation. This decrease in RUNX2 expression/activity may be due to a
lack of necessary estrogenic compounds, however, this does not wholly mean
estrogen is required as the results clearly indicate that RUNX2 is in fact functioning
properly which is indicative of the osteoblast-like phenotype.
RT-PCR quantification of gene expression for the selected markers showed
that estrogenic compounds were not necessary for proper osteoblast-like cell growth
or constitutive molecule formation and activity. This pattern is supported by the
production of osteoprotegrin and the apparent formation of the PTH-receptor (Figures

51

5 and 7). Because OPG is produced in response to reduced circulating estrogen then
cells cultured in media devoid of estrogenic compounds should not produce the decoy
RANKL receptor. However, the results ofRT-PCR identify OPG production at an
increased rate when compared to cells grown in media with estrogen. The PTHR-1
receptor complex interacts with PTH on the surface of developing bone and and
internalizes to process the received signal. Since osteoblast-like cells supposedly
require media supplemented with estrogenic compounds to grow (Kameda et al.,
1997), the results indicating PTHR-1 production in media lacking estrogenic .
compounds shows otherwise; a significant difference was observed when cells grown
in media without FBS compared to those supplemented with 10% FBS.
Above all cells cultured in media should simply grow properly lacking
irregularities in shape, appearance, and function. Figures 2 and 3 identify those cells
grown in media with a reduced estrogen concentration (no FBS supplementation)
maintain expected cell morphology and exhibit a pattern of growth suitable for
research purposes, respe,ctively.
Considering these results, we feel that the developed protocol will allow the
study of osteoclast-like cells in a media with reduced estrogen levels while
maintaining the phenotype of the cell.
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5 and 7). Because OPG is produced in response to reduced circulating estrogen then
cells' cultured in media devoid of estrogenic compounds should not produce the decoy
RANKL receptor. However, the results ofRT-PCR identify OPG production at an
increased rate when compared to cells grown in media with estrogen. The PTHR-1
receptor complex interacts with PTH on the surface of developing bone and and
internalizes to process the received signal. Since osteoblast-like cells supposedly
require media supplemented with estrogenic compounds to grow (Kameda et al.,
1997), the results indicating PTHR-1 production in media lacking estrogenic
compounds shows otherwise; a significant difference was observed when cells grown
in media without FBS compared to those supplemented with I 0% FBS.
Above all cells cultured in media should simply grow properly lacking
irregularities in shape, appearance, and fimction. Figures 2 and 3 identify those cells
grown in media with a reduced estrogen concentration (no FBS supplementation)
maintain expected cell morphology and exhibit a pattern of growth suitable for
research purposes, respectively.
Considering these results, we feel that the developed protocol will allow the
study of osteoclast-like cells in a media with reduced estrogen levels while
maintaining the phenotype of the cell.
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